414
Participants
Start Date
November 20, 2019
Primary Completion Date
June 20, 2026
Study Completion Date
September 20, 2028
Nab-paclitaxel + Carboplatin
nab-paclitaxel given IV at 125 mg/m\^2 on days 1, 8 and carboplatin given IV at AUC 5 on days 1 every 21 days x 6 cycles；
Nab-paclitaxel + Capecitabine
Nab-paclitaxel given IV at 125 mg/m\^2 on days 1, 8 and capecitabine given IV at 1000 mg/m\^2 bid, d1-14 every 21 days x 6 cycles；
RECRUITING
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Collaborators (1)
Beijing 302 Hospital
OTHER
CSPC Ouyi Pharmaceutical Co., Ltd.
INDUSTRY
Hebei Medical University Fourth Hospital
OTHER